NCT03780179View on ClinicalTrials.gov

MMR at 6 Months Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

6,540

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

January 7, 2022

Study Completion Date

January 7, 2022

Conditions
Meales-mumps-rubella Vaccine
Interventions
BIOLOGICAL

MMRvaxpro

MMRvaxpro vaccine

BIOLOGICAL

Placebo

Placebo

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

2730

Herlev Hospital, Herlev

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03780179 - MMR at 6 Months Trial | Biotech Hunter | Biotech Hunter